Guidance for industry [electronic resource] : new contrast imaging indication considerations for devices and approved drug and biological products.
Imprint
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Combination Products (OCP) in Office of Commissioner : Center for Devices and Radiological Health (CDRH) : Center for Drug Evaluation and Research (CDER), [2008]
